Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-064588
Filing Date
2024-05-24
Accepted
2024-05-24 16:10:13
Documents
1
Period of Report
2024-05-23

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3832
  Complete submission text file 0000950170-24-064588.txt   5553
Mailing Address C/O ARENA PHARMACEUTICALS, INC. 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address C/O ARENA PHARMACEUTICALS, INC. 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 (858) 453-7200
Aurentz Vincent (Reporting) CIK: 0001657494 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40192 | Film No.: 24984377

Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Issuer) CIK: 0001832168 (see all company filings)

EIN.: 845009619 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)